-
Something wrong with this record ?
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology
DBP. Eekers, D. Di Perri, E. Roelofs, A. Postma, J. Dijkstra, T. Ajithkumar, C. Alapetite, M. Blomstrand, NG. Burnet, V. Calugaru, I. Compter, IEM. Coremans, S. Harrabi, A. Iannalfi, YLB. Klaver, M. Lambrecht, AM. Romero, F. Paulsen, B....
Language English Country Ireland
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Organs at Risk MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Radiotherapy Planning, Computer-Assisted * MeSH
- Tomography, X-Ray Computed MeSH
- Radiation Oncology * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND AND PURPOSE: To update the digital online atlas for organs at risk (OARs) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging with new OARs. MATERIALS AND METHODS: In this planned update of the neurological contouring atlas published in 2018, ten new clinically relevant OARs were included, after thorough discussion between experienced neuro-radiation oncologists (RTOs) representing 30 European radiotherapy-oncology institutes. Inclusion was based on daily practice and research requirements. Consensus was reached for the delineation after critical review. Contouring was performed on registered CT with intravenous (IV) contrast (soft tissue & bone window setting) and 3 Tesla (T) MRI (T1 with gadolinium & T2 FLAIR) images of one patient (1 mm slices). For illustration purposes, delineation on a 7 T MRI without IV contrast from a healthy volunteer was added. OARs were delineated by three experienced RTOs and a neuroradiologist based on the relevant literature. RESULTS: The presented update of the neurological contouring atlas was reviewed and approved by 28 experts in the field. The atlas is available online and includes in total 25 OARs relevant to neuro-oncology, contoured on CT and MRI T1 and FLAIR (3 T & 7 T). Three-dimensional (3D) rendered films are also available online. CONCLUSION: In order to further decrease inter- and intra-observer OAR delineation variability in the field of neuro-oncology, we propose the use of this contouring atlas in photon and particle therapy, in clinical practice and in the research setting. The updated atlas is freely available on www.cancerdata.org.
Clinic for Particle Therapy University Hospital Essen West German Cancer Center Germany
Clinical Department Radiotherapy Unit National Center for Oncological Hadrontherapy Pavia Italy
Danish Centre for Particle Therapy Aarhus Denmark
Department of Medical Psychology MUMC Maastricht The Netherlands
Department of Oncology Cambridge University Hospitals NHS Foundation Trust United Kingdom
Department of Oncology Sahlgrenska University Hospital Gothenburg Sweden
Department of Radiation Oncology Cliniques universitaires Saint Luc Brussels Belgium
Department of Radiation Oncology Eberhard Karls Universität Tübingen Germany
Department of Radiology and Nuclear Medicine MUMC Maastricht The Netherlands
Department of Radiotherapy Heidelberg Germany
Department of Radiotherapy Oncology Leuven Kanker Instituut UZ Gasthuisberg Belgium
German Cancer Consortium Germany
German Cancer Consortium partnersite Essen Essen Germany
German Cancer Research Center Heidelberg Germany
Haaglanden Medisch Centrum Department of Radiotherapy Leidschendam The Netherlands
Helmholtz Association Helmholtz Zentrum Dresden Rossendorf Germany
Helmholtz Zentrum Dresden Rossendorf Institute of Radiooncology OncoRay Dresden Germany
HollandPTC Delft The Netherlands
Institut Curie Radiation Oncology Department Paris and Proton Center Orsay France
Institute Curie Centre de Protonthérapie d'Orsay Orsay France
Leiden University Medical Centre Department of Radiotherapy Leiden The Netherlands
National Center for Tumor Diseases Partner Site Dresden Germany
Paul Scherrer Institut Center for Proton Therapy Villigen PSI Switzerland
Proton Therapy Center Czech Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025497
- 003
- CZ-PrNML
- 005
- 20211026133745.0
- 007
- ta
- 008
- 211013s2021 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.radonc.2021.05.013 $2 doi
- 035 __
- $a (PubMed)34015385
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Eekers, Daniëlle B P $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands. Electronic address: danielle.eekers@maastro.nl
- 245 10
- $a Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology / $c DBP. Eekers, D. Di Perri, E. Roelofs, A. Postma, J. Dijkstra, T. Ajithkumar, C. Alapetite, M. Blomstrand, NG. Burnet, V. Calugaru, I. Compter, IEM. Coremans, S. Harrabi, A. Iannalfi, YLB. Klaver, M. Lambrecht, AM. Romero, F. Paulsen, B. Timmermann, P. Vitek, HL. van der Weide, GA. Whitfield, PW. Nyström, J. Zindler, D. de Ruysscher, J. Langendijk, DC. Weber, EGC. Troost
- 520 9_
- $a BACKGROUND AND PURPOSE: To update the digital online atlas for organs at risk (OARs) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging with new OARs. MATERIALS AND METHODS: In this planned update of the neurological contouring atlas published in 2018, ten new clinically relevant OARs were included, after thorough discussion between experienced neuro-radiation oncologists (RTOs) representing 30 European radiotherapy-oncology institutes. Inclusion was based on daily practice and research requirements. Consensus was reached for the delineation after critical review. Contouring was performed on registered CT with intravenous (IV) contrast (soft tissue & bone window setting) and 3 Tesla (T) MRI (T1 with gadolinium & T2 FLAIR) images of one patient (1 mm slices). For illustration purposes, delineation on a 7 T MRI without IV contrast from a healthy volunteer was added. OARs were delineated by three experienced RTOs and a neuroradiologist based on the relevant literature. RESULTS: The presented update of the neurological contouring atlas was reviewed and approved by 28 experts in the field. The atlas is available online and includes in total 25 OARs relevant to neuro-oncology, contoured on CT and MRI T1 and FLAIR (3 T & 7 T). Three-dimensional (3D) rendered films are also available online. CONCLUSION: In order to further decrease inter- and intra-observer OAR delineation variability in the field of neuro-oncology, we propose the use of this contouring atlas in photon and particle therapy, in clinical practice and in the research setting. The updated atlas is freely available on www.cancerdata.org.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a kritické orgány $7 D058958
- 650 12
- $a radiační onkologie $7 D018787
- 650 12
- $a plánování radioterapie pomocí počítače $7 D011880
- 650 _2
- $a počítačová rentgenová tomografie $7 D014057
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Di Perri, Dario $u Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium
- 700 1_
- $a Roelofs, Erik $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a Postma, Alida $u Department of Radiology and Nuclear Medicine MUMC+, Maastricht, The Netherlands
- 700 1_
- $a Dijkstra, Jeanette $u Department of Medical Psychology MUMC+, Maastricht, The Netherlands
- 700 1_
- $a Ajithkumar, Thankamma $u Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, United Kingdom
- 700 1_
- $a Alapetite, Claire $u Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France
- 700 1_
- $a Blomstrand, Malin $u Department of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden
- 700 1_
- $a Burnet, Neil G $u The Christie NHS Foundation Trust, Manchester, United Kingdom
- 700 1_
- $a Calugaru, Valentin $u Institute Curie, Paris, France; Institute Curie, Centre de Protonthérapie d'Orsay, Orsay, France
- 700 1_
- $a Compter, Inge $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a Coremans, Ida E M $u Leiden University Medical Centre, Department of Radiotherapy, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands
- 700 1_
- $a Harrabi, Semi $u Department of Radiotherapy, Heidelberg, Germany
- 700 1_
- $a Iannalfi, Alberto $u Clinical Department, Radiotherapy Unit, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy
- 700 1_
- $a Klaver, Yvonne L B $u Leiden University Medical Centre, Department of Radiotherapy, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands
- 700 1_
- $a Lambrecht, Maarten $u Department of Radiotherapy-Oncology, Leuven Kanker Instituut, UZ Gasthuisberg, Belgium
- 700 1_
- $a Romero, Alejandra Méndez $u HollandPTC, Delft, The Netherlands; Department of Radiotherapy, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands
- 700 1_
- $a Paulsen, Frank $u Department of Radiation Oncology, Eberhard-Karls-Universität Tübingen, Germany
- 700 1_
- $a Timmermann, Beate $u Clinic for Particle Therapy, University Hospital Essen, West German Cancer Center (WTZ), Germany; West German Proton Therapy Center Essen (WPE), Germany; German Cancer Consortium (DKTK), partnersite Essen, Essen, Germany
- 700 1_
- $a Vitek, Pavel $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a van der Weide, Hiske L $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
- 700 1_
- $a Whitfield, Gillian A $u The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, United Kingdom; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, United Kingdom
- 700 1_
- $a Nyström, Petra Witt $u Danish Centre for Particle Therapy, Aarhus, Denmark
- 700 1_
- $a Zindler, Jaap $u HollandPTC, Delft, The Netherlands; Haaglanden Medisch Centrum, Department of Radiotherapy, Leidschendam, The Netherlands
- 700 1_
- $a de Ruysscher, Dirk $u Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, The Netherlands
- 700 1_
- $a Langendijk, Johannes $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands
- 700 1_
- $a Weber, Damien C $u Paul Scherrer Institut, Center for Proton Therapy, Villigen-PSI, Switzerland
- 700 1_
- $a Troost, Esther G C $u Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf Dresden, Germany; German Cancer Consortium (DKTK), partnersite Dresden and German Cancer Research Center (DKFZ), Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresde, Germany; Helmholtz Association / Helmholtz-Zentrum Dresden - Rossendorf (HZDR)., Germany
- 773 0_
- $w MED00004049 $t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 160, č. - (2021), s. 259-265
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34015385 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133751 $b ABA008
- 999 __
- $a ok $b bmc $g 1714520 $s 1146004
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 160 $c - $d 259-265 $e 20210518 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
- LZP __
- $a Pubmed-20211013
